Applied Clinical Trials Direct
Having trouble viewing this e-mail? Click here.
  February 12, 2013
 
In This Edition
News Roundup: Avoca Quality Consortium’s 2013 Initiatives
Blog Posts: Phase I Budgetary Importance
Marketplace: Marketplace

News Roundup
bullet Avoca Quality Consortium Announces 2013 Initiatives
Lilly and Pfizer continue as lead Consortium sponsors, with 29 member companies.
bullet ERT, University Researchers Expand CF Home Health Monitoring Study
Patients are using ERT’s AM2+ lung function monitors, an integrated, portable spirometer and electronic diary.
bullet Regulatory Changes in Russia
Russian regulators implement much awaited changes to the nation's regulatory process for medical devices, which took effect at the start of January.
bullet EMA’s PV Risk Assessment Committee Meets
Highlights and materials from the PRAC meeting in early February are released.
Blogs Posts
bullet Phase I Trials Take on Greater Budgetary Importance
Oracle Health Sciences ClearTrial software adds Phase I and complex trial functions for increased budgetary needs.
bullet Three Steps to Better Decisions
Kevin Connor of Decision Lens looks at three principles that can reduce risk and increase the probability of drug development success.

Webcasts & Events
bullet ClinTech 2013--eTMF, CTMS, Portals, EDC

Marketplace

Sponsored
BioClinica
Free Webinar: MRI-based Eligibility and Safety Evaluations in Alzheimer´s Disease Trials. Learn the current standards and operational considerations in monitoring the safety of new therapeutic compounds for treating AD. Click Here

Sponsored
Capsugel
DBcaps® capsules are uniquely designed for double-blind clinical trials.  They can improve patient compliance, as well as reduce bias, when used in clinical trials to over-encapsulate comparator products. www.capsugel.com

Follow Us

Ask The Editor

Lisa Henderson
Editor in Chief [email protected]